Human TNF mutants with selective activity on the p55 receptor

Nature

Volumn 361, Issue 6409, 1993, Pages 266-269

  Ostade, Xaveer Van ^a   Vandenabeele, Peter ^a   Everaerdt, Bart ^a   Loetscher, Hansruedi ^b   Gentz, Reiner ^b   Brockhaus, Manfred ^b   Lesslauer, Werner ^b   Tavernier, Jan ^c   Brouckaert, Peter ^a   Fiers, Walter ^a  

^a GHENT UNIVERSITY   (Belgium)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

^c Roche Research   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

MURINAE; MUS MUSCULUS;

MUTANT PROTEIN; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CYTOTOXICITY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADENOCARCINOMA; AMINO ACID SEQUENCE; ANIMAL; BINDING, COMPETITIVE; CELL SURVIVAL; COLONIC NEOPLASMS; COMPARATIVE STUDY; CYCLOHEXIMIDE; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMAN; KINETICS; L CELLS (CELL LINE); MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; POINT MUTATION; RECEPTORS, CELL SURFACE; RECEPTORS, TUMOR NECROSIS FACTOR; RECOMBINANT PROTEINS; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR;

EID: 0027392199     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/361266a0     Document Type: Article

References (59)

1. Mery, P. F., Lohmann, S. M., Walter, U. & Fischmeister, R. Proc. natn. Acad. Sci. U.S.A. 88, 197-1201 (1991).
2. Tohse, N. & Sperelakis, N. Circ. Res. 69, 325-331 (1991).
3. Dayanithi, G. & Antoni. F. A. J. Endocrin. 125, 39-44 (1990).
4. Antoni, F. A. & Dayanithi, G. J. Endocrin. 126, 183-191 (1990).
5. White, R. E., Schonbrunn, A. & Armstrong, D. L. Nature 351, 570-573 (1991).
6. Goldberg, N. D 0'Dea, R. F. & Haddox, M. K. Adv. Cyclic Nucleotide Res. 3, 155-213 (1973).
7. Bialojan, C. & Takai, A. Biochem. J. 256, 283-290 (1988).
8. Dorflinger, L. J. & Schonbrunn, A. Endocrinology 13, 1541-1550 (1983).
9. Schonbrunn, A. Metabolism 39 (suppl. 2), 96-100 (1990).
10. Shabb, J. B. & Corbin, J. D. J. blol. Chem. 267, 5723-5726 (1992).
11. Beavo, J. A. Adv. Second Messenger Phosphoprotein Res. 22, 1-38 (1988).
12. Williams, D. L., Katz, G. M., Roy-Constancin, L. & Reuben, J. P. Proc. natn. Acad. Sci. U.S.A. 85, 9360-9364 (1988).
13. Hidaka, H. & Kobayashi, R. A. Rev. Pharmac. Toxic. 32, 377-397 (1992).
14. Sikdar, S. K Mcintosh. R. P. & Mason, W. T. Brain Res. 496, 113-123 (1989).
15. Cheng, H. et al. J. biol. Chem. 261, 989-992 (1986).
16. Hescheler, J. et al. Eur. J. Biochem. 165, 261-266 (1987).
17. Reinhart, P. H. et al. J. Neurosci. 11, 1627-1635 (1991).
18. Armstrong, D. L. Trends Neurosci. 12, 117-122 (1989).
19. Armstrong, D. & Eckert, R. Proc. natn. Acad. Sci. U.S.A. 84, 2518-2522 (1987).
20. Ohya, Y. & Sperelakis, N. Pflugers Arch. 414, 257-264 (1989).
21. Ono, K. & Fozzard, H. A. J. Physiol., Lond. 454, 673-688 (1992).
22. Korn, S. J. & Horn, R. J. gen. Physiol. 94, 789-812 (1989).
23. Steiner, A. L. Methods of Hormone Radioimmunoassay 2nd edn 3-16 (Academic. New York. 1979).
24. Tang, J. M., Wang, J., Quandt, F. N. & Eisenberg, R. S. Pflugers Arch. 416, 347- 350 (1990).
25. Lincoln, T. M. Meth. Enzym. 99, 62-71 (1983).
26. Brenner, B. M., Ballermann, B. J., Gunning, M. E. & Zeidel, M. L. Physiol. Rev. 70, 665-699 (1990).
27. Fischmeister, R. & Hartzell, H. C. J. Physiol. 387, 453-472 (1987).
28. Fiers, W. FEBS Lett. 285, 199-212 (1991).
29. Sugarman, B. J. et al. Science 230, 943-945 (1985).
30. Fransen, L, Van der Heyden, J., Ruysschaert, R. & Fiers, W. Eur. J. Cancer din. Oncol. 22, 419-426 (1986).
31. Old, L. J. in Tumor Necrosis Factor: Structure, Mechanism of Action, Role in Disease and Therapy (eds Bonavida, B. & Granger, G.) 1-30 (Karger. Basel, 1990).
32. Taguchi, T. & Sohmura, Y. Biotherapy 3, 177-186 (1991).
33. lienard, D., Lejeune, F., Delmotte, J.-J., Renard, N. & Ewalenko, P. J. din. Oncol. 10, 52-60 (1992).
34. Brouckaert, P. G. G., Leroux-Roels, G. G., Guisez, Y., Tavernier, J. & Fiers, W. Int. J. Cancer 38, 763-769 (1986).
35. Malik, S. T. A. & Balkwill, F. R. in Tumor Necrosis Factors. Structure, Function, and Mechanism of Action (eds Aggarwal, B. B- & VilCek, J.) 239-268 (Dekker, New York, 1992).
36. Takahashi, N., Brouckaert, P. & Fiers, W. Cancer Res. 51, 2366-2372 (1991).
37. Everaerdt, B., Brouckaert, P., Shaw, A. & Fiers, W. Biochem. biophys. Res. Commun. 163, 378-385 (1989).
38. Brouckaert, P., Libert, C., Everaerdt, B. & Fiers, W. Lymph. Cyt. Res. 11, 193-196 (1992).
39. Fransen, L., Ruysschaert, M. R., Van der Heyden, J. & Fiers, W. Cell. Immun. 100, 260-267
40. Kramer, S. M. et al. Cancer Res. 48, 920-925 (1988).
41. Tartaglia, L. A. & Goeddel, D. V. Immun. Today 13, 151-153 (1992).
42. Loetscher, H., Steinmetz, M. & Lesslauer, W. Cancer Cells 3, 221-226 (1991).
43. Brockhaus, M. et al. Proc. natn. Acad. Sci. U.S.A. 87, 3127-3131 (1990).
44. Gehr, G., Gentz, R., Brockhaus, M., Lotscher, H. & Lesslauer, W. J. Immun. 149, 911-917 (1992).
45. Tartaglia, L. A. et al. Proc. natn. Acad. Sci. U.S.A. 88, 9292-9296 (1991).
46. Brouckaert, P., Everaerdt, B. & Fiers, W. Eur. J. Immun. 22, 981-986 (1992).
47. Van Ostade, X., Tavernier, J., Prange, T. & Fiers, W. EMBO J. 10, 827-836 (1991).
48. Yamagishi, J. et al. Protein Engng. 3, 713-719 (1990).
49. Plaetinck, G., Declercq, W., Tavernier, J., Nabholz, M. & Fiers, W. Eur. J. Immun. 17, 1835-1838
50. Vandenabeele, P. et al. Lymphokine Res. 9, 381-389 (1990).
51. Heller, R. A., Song, K, Fan. N. & Chang, D. J. Cell 70, 47-56 (1992).
52. Lesslauer, W. et al. Eur. J. Immun. 21, 2883-2886 (1991).
53. Conzelmann, A., Corthesy, P., Cianfriglia, M., Silva, A. & Nabholz, M. Nature 298, 170-172 (1982).
54. de la Luna, S., Soria, I., Pulido, D., Ortin J. & Jimenez, A. Gene 62, 121-126 (1988).
55. Chinkers, M. et al. Nature 338, 78-83 (1989).
56. Goy, M. F. Trends neurosci. 14, 293-299 (1991).
57. Doerner, D. & Alger, B. E. Neuron 1, 693-699 (1988).
58. Light, D. B., Corbin, J. D. & Stanton, B. A. Nature 344, 336-339 (1990).
59. Spriggs, D. R. & Yates, S. W. in Tumor Necrosis Factors: The Molecules and Their Emerging Role in Medicine (ed. Beutler, B.) 383-406 (Raven, New York. 1992).